Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Cash from Financing Activities (2016 - 2025)

Healthy Extracts' Cash from Financing Activities history spans 11 years, with the latest figure at -$486274.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 1506.99% year-over-year to -$486274.0; the TTM value through Dec 2025 reached -$186906.0, up 1.31%, while the annual FY2025 figure was -$186906.0, 1.31% up from the prior year.
  • Cash from Financing Activities reached -$486274.0 in Q4 2025 per HYEX's latest filing, down from $268829.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $846880.0 in Q1 2021 to a low of -$486274.0 in Q4 2025.
  • Average Cash from Financing Activities over 5 years is $69648.0, with a median of $35458.5 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: surged 3755.28% in 2023, then tumbled 1506.99% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $77199.0 in 2021, then surged by 79.7% to $138730.0 in 2022, then plummeted by 159.52% to -$82574.0 in 2023, then surged by 63.35% to -$30260.0 in 2024, then crashed by 1506.99% to -$486274.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Cash from Financing Activities are -$486274.0 (Q4 2025), $268829.0 (Q3 2025), and $83782.0 (Q2 2025).